Development of a methodology for dose assessment and estimate of amount of NORM residues disposable in a conventional landfill.

The final disposal of NORM wastes in conventional landfill generally determines problems of acceptance by the landfill operators, since their willingness to accept Naturally Occurring Radioactive Material (NORM) is often limited due to their concern about the radiological risks and reluctance of the local community to have at local landfills material that despite being cleared is still perceived as 'radioactive'. In order to raise awareness among landfill operators, and also among other stakeholders on the actual radiological risk of exempted or cleared NORM wastes, it is of interest to estimate the mass of annual wastes containing NORM that can be disposed of in a landfill for conventional waste complying with the annual dose criterion of 1 mSv. A methodology was developed considering a hypothetical homogeneous large landfill and assuming that NORM wastes are delivered with an initial activity concentration of 1 kBq kg.

Development of a methodology for assessing radiological dose due to use of NORM sludge as fertilizer.

In Europe, the general obligation to recycle drives for increased reuse of residues containing Naturally Occurring Radioactive Material (NORM). In agriculture, this has led to the reuse of sludge produced by groundwater filtration facilities as a means of fertilization. In the frame of the RadoNorm project, a methodology was developed for dose assessment of agricultural workers and other members of the public living near agricultural fields in which NORM-containing sludge is applied.

A methodology for the systematic identification of naturally occurring radioactive materials (NORM).

Naturally occurring radioactive materials (NORM) are present worldwide and under certain circumstances (e.g., human activities) may give radiation exposure to workers, local public or occasional visitors and non-human biota (NHB) of the surrounding ecosystems.

Gitelman syndrome associated with chondrocalcinosis and severe neuropathy: a novel heterozygous mutation in SLC12A3 gene.

Gitelman syndrome (GS) is an inherited salt-wasting tubulopathy characterized by hypocalciuria, hypokalemia, hypomagnesemia and metabolic alkalosis, due to inactivating mutations in the SLC12A3 gene. Symptoms may be systemic, neurological, cardiovascular, ophthalmological or musculoskeletal. We describe a 70 year-old patient affected by recurrent arthralgias, hypoesthesia and hyposthenia in all 4 limbs and severe hypokalemia, complicated by atrial flutter.